Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Decline in Pharmaceutical Sales in The Cape Coral, Fla. Market Due to High Uninsurance Rates and Generic Utilization Will Be Offset by the Establishment of High-Risk Pool and ...

November 4, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., Nov. 4, 2010 /- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that while the Cape Coral, Fla. market will face a decline in pharmaceutical sales due to rising uninsurance and increased generic utilization, the development of...

ECRI Institute Awarded AHRQ Contract to Establish National Healthcare Horizon Scanning System

November 4, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

PLYMOUTH MEETING, Pa., Nov. 4, 2010 /PRNewswire-USNewswire/ -- ECRI Institute , an independent nonprofit that researches the best approaches to improving patient care, has been awarded a multi-year contract from the U.S. Agency for Healthcare Research and Quality (AHRQ) to establish the...

Covidien Receives FDA 510(k) Clearance for Kendall SCD(TM) Compression Comfort Sleeve and Kendall SCD(TM) 700 Series Controller

November 4, 2010 3:32 am | by Covidien | News | Comments

New System Delivers Improved Comfort and Clinically Proven Compression Technology for Venous Thromboembolism MANSFIELD, Mass., Nov 04, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in intermittent pneumatic...


Actavis Encourages Consumers to Return Fentanyl Transdermal System 25 mcg/h

November 3, 2010 9:34 pm | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J., Nov. 3, 2010 /- Further to its previously announced voluntary recall of 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches, Actavis is encouraging consumers to return any product in their possession from the October 21, 2010 recall. Consumers with Actavis 25...

Americans less healthy than English, but live as long or longer, study finds

November 3, 2010 9:33 pm | by EurekAlert | News | Comments

(RAND Corporation) Older Americans are less healthy than their English counterparts, but they live as long or even longer than their English peers, according to a new study.Researchers found that while Americans aged 55 to 64 have higher rates of chronic diseases than their peers in...

Medicare Bidding System for Medical Equipment Plagued by Flaws, Delays, Lack of Transparency

November 3, 2010 5:34 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON, Nov. 3, 2010 /PRNewswire-USNewswire/ -- The inherent design flaws, long overdue announcement of winners, and lack of transparency in Medicare's controversial "competitive" bidding program for home medical equipment have made it difficult for homecare patients and providers to...

Sleeping pills not easy answer

November 3, 2010 12:32 pm | by Baylor College of Medicine | News | Comments

When sleep doesn't come easily, some people turn to what they think is an easy solution – sleeping pills. But according to a Baylor College of Medicine sleep expert, sleep medications – whether prescription or over-the-counter – shouldn't be taken lightly. "All...

Cleveland Clinic Unveils Top 10 Medical Innovations for 2011

November 3, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Nov. 3, 2010 /- From pill-sized cameras to radioactive compounds that let doctors "see" inside a patient's brain, Cleveland Clinic's Top 10 Medical Innovations for 2011 showcases new techniques, therapies and approaches to treating a host of diseases. The list of breakthrough...


DNA Medicine Institute Receives Qualifying Therapeutic Discovery Grant

November 3, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., Nov. 3, 2010 /- The DNA Medicine Institute, a biomedical research organization whose mission is to advance patient care, alleviate human suffering, and treat disease through innovation, has received a $222,999 grant from the U.S. government under the Qualifying...

GREENGUARD's First Exhibit at HEALTHCARE DESIGN.10 to Help Architects and Designers Specify Healthier Products More Easily and Efficiently

November 2, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Nov. 2, 2010 /PRNewswire-USNewswire/ -- Architects and designers who visit the GREENGUARD Environmental Institute 's first-ever HEALTHCARE DESIGN.10 exhibit next week will have the opportunity to learn how low-emitting products and materials can help create healthier, more...

Varian Medical Systems to Supply Four Advanced Radiotherapy Treatment Machines to Global Hospitals in India

November 2, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

HYDERABAD, India, Nov. 2, 2010 /- Advanced cancer treatments across India will become more widely available with the order of four state-of-the-art Varian Medical Systems (NYSE: VAR ) medical linear accelerators by Global Hospitals, one of the nation's leading private hospital groups....

CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance

November 2, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 2, 2010 /- CareFusion Corp. (NYSE: CFN ), a leading, global medical device company, today reported results for the three months ended Sept. 30, 2010. "Our adjusted EPS results for the first quarter were in line with our expectations, and highlighted a strong quarter for...

Bronchial Thermoplasty Demonstrates Long-Term Asthma Control in Patients With Severe Asthma

November 2, 2010 5:33 am | by Boston Scientific | News | Comments

Two-year data presented at CHEST 2010 demonstrate ability of FDA-approved, non-drug asthma treatment to provide long-lasting symptom control


Baxa to Sponsor ASHP Midday Symposium - The Power of Control: Using Pharmacy Software Tools to get Control of your Workflow, Ensure Quality Control and Support Patient Safety ...

November 1, 2010 11:35 am | by Bio-Medicine.Org | News | Comments

ENGLEWOOD, Colo., Nov. 1, 2010 /- Baxa Corporation , a leading provider of medical devices and systems that automate pharmacy operations and increase patient safety, today announced its sponsorship of a customer forum at the 45th American Society of Health-System Pharmacists (ASHP)...

Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010

November 1, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Nov. 1, 2010 /- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that it will report results for its fiscal quarter ended September 30, 2010, on Tuesday, November 9, 2010 following the close of the U.S. financial markets.  As the Company recently...

Veroâ„¢ SBRT Unleashed

November 1, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 1 /- ASTRO, the annual meeting of the American Society for Therapeutic Radiology and Oncology, marks the introduction of Vero™ SBRT to the broader North American audience. The Vero SBRT system offers the latest in radiation technology: dynamic tumor tracking and...

CyberKnife Radiosurgery for Early-Stage Breast Cancer

October 31, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Oct. 31 /- Accuray Incorporated, (Nasdaq:  ARAY), a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of...

Surrogate decision makers wish to retain authority in difficult decision

October 29, 2010 4:35 pm | by EurekAlert | News | Comments

(American Thoracic Society) The decision to stop life-support for incapacitated and critically ill patients is, for surrogate decision makers, often fraught with moral and ethical uncertainty, and long-term emotional consequences. But as difficult as these decisions are, more than half of...

Allergy Update: Know your treatment options

October 29, 2010 4:34 pm | by Baylor College of Medicine | News | Comments

Allergies got you down? Dr. Madhu Narra , assistant professor of medicine in the section of allergy, immunology and rheumatology at Baylor College of Medicine discusses potential treatment options. Classic allergy symptoms include runny and itchy eyes and nose, sneezing, congestion,...

Accuray's CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting

October 29, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Oct. 29 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that 40 accepted abstracts highlighting the use of the CyberKnife Robotic Radiosurgery System will be presented as posters and presentations at the 52nd Annual...

CyberKnife® VSI™ System Expands Treatment Applications and Significantly Reduces Treatment Times

October 29, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Oct. 29 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today feedback from Creekside Cancer Care on their use of the CyberKnife VSI System .  Creekside Cancer Care was the first facility in the world to install and...

Varian Medical Systems to Exhibit TrueBeam™ System for Image-Guided Cancer Treatments and New Software Capabilities at ASTRO Meeting in San Diego

October 28, 2010 12:31 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 28 /- ASTRO Booth # 201 -- Varian Medical Systems (NYSE: VAR ) will highlight its new TrueBeam™ system for fast, powerful and efficient cancer treatments at the 52nd annual meeting of the American Society for Radiation Oncology (ASTRO) meeting in San Diego next week....

Jekyll-Hyde MicroRNA Binding Variant Linked to Improved Outcome in Early-stage Colorectal Cancer

October 28, 2010 11:33 am | by AACR | News | Comments

PHILADELPHIA — A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology...

UM School of Medicine receives $45 million private donation for celiac research

October 28, 2010 8:32 am | by EurekAlert | News | Comments

(University of Maryland Medical Center) With a new $45 million private gift from the family of a grateful patient, the University of Maryland School of Medicine is planning to establish the nation's only major research enterprise devoted to the study of autoimmune and inflammatory...

Amira Pharmaceuticals Announces Initiation of Phase I Clinical Trial for AM152, A Novel LPA1 Antagonist

October 28, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 28 /- Amira Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study with AM152, a novel LPA1 antagonist, in normal, healthy subjects. "We are excited to begin our journey exploring the therapeutic value of AM152, a potentially novel...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.